Growth factor receptor-bound protein: Difference between revisions
Jump to navigation
Jump to search
Michal Harel (talk | contribs) No edit summary |
Michal Harel (talk | contribs) No edit summary |
||
Line 9: | Line 9: | ||
Updated on {{REVISIONDAY2}}-{{MONTHNAME|{{REVISIONMONTH}}}}-{{REVISIONYEAR}} | Updated on {{REVISIONDAY2}}-{{MONTHNAME|{{REVISIONMONTH}}}}-{{REVISIONYEAR}} | ||
{{#tree:id=OrganizedByTopic|openlevels=0| | |||
*GRB2 | |||
[[1gri]], [[2h46]] – hGRB2 – human <br /> | **[[1gri]], [[2h46]] – hGRB2 – human <br /> | ||
''GRB2 C terminal SH3 domain'' | *''GRB2 C terminal SH3 domain'' | ||
[[1gfc]], [[1gfd]] – hGRB2 C terminal SH3 domain - NMR<br /> | **[[1gfc]], [[1gfd]] – hGRB2 C terminal SH3 domain - NMR<br /> | ||
[[2vvk]], [[2vwf]], [[2w0z]] – hGRB2 C terminal SH3 domain <br /> | **[[2vvk]], [[2vwf]], [[2w0z]] – hGRB2 C terminal SH3 domain <br /> | ||
[[1io6]] – hGRB2 C terminal SH3 domain + ligand peptide - NMR<br /> | **[[1io6]] – hGRB2 C terminal SH3 domain + ligand peptide - NMR<br /> | ||
[[1gcq]] – hGRB2 C terminal SH3 domain + VAV proto-oncogene SH3 domain<br /> | **[[1gcq]] – hGRB2 C terminal SH3 domain + VAV proto-oncogene SH3 domain<br /> | ||
''GRB2 N terminal SH3 domain'' | *''GRB2 N terminal SH3 domain'' | ||
[[1gbr]], [[1gbq]], [[2gbq]], [[3gbq]], [[4gbq]] – mGRB2 N terminal SH3 domain + Sos-A peptide – mouse - NMR<br /> | **[[1gbr]], [[1gbq]], [[2gbq]], [[3gbq]], [[4gbq]] – mGRB2 N terminal SH3 domain + Sos-A peptide – mouse - NMR<br /> | ||
[[1aze]] – mGRB2 N terminal SH3 domain + Sos-A peptide - NMR<br /> | **[[1aze]] – mGRB2 N terminal SH3 domain + Sos-A peptide - NMR<br /> | ||
''GRB2 SH2 domain'' | *''GRB2 SH2 domain'' | ||
[[1jyu]] – hGRB2 SH2 domain <br /> | **[[1jyu]] – hGRB2 SH2 domain <br /> | ||
[[1ghu]] – hGRB2 SH2 domain (mutant) - NMR<br /> | **[[1ghu]] – hGRB2 SH2 domain (mutant) - NMR<br /> | ||
[[1fhs]] – hGRB2 SH2 domain - NMR<br /> | **[[1fhs]] – hGRB2 SH2 domain - NMR<br /> | ||
[[1x0n]] – hGRB2 SH2 domain + inhibitor - NMR<br /> | **[[1x0n]] – hGRB2 SH2 domain + inhibitor - NMR<br /> | ||
[[2huw]] – hGRB2 SH2 domain + cyclopropane derivative<br /> | **[[2huw]] – hGRB2 SH2 domain + cyclopropane derivative<br /> | ||
[[1cj1]] – hGRB2 SH2 domain + phosphor-Tyr derivative<br /> | **[[1cj1]] – hGRB2 SH2 domain + phosphor-Tyr derivative<br /> | ||
[[2aoa]], [[2aob]] – hGRB2 SH2 domain + peptide mimetic<br /> | **[[2aoa]], [[2aob]] – hGRB2 SH2 domain + peptide mimetic<br /> | ||
[[1tze]], [[1bmb]], [[1bm2]], [[1zfp]], [[1fyr]], [[1jyq]], [[1jyr]], [[2h5k]], [[3c7i]], [[3imd]], [[3imj]], [[3in7]], [[3in8]], [[3kfj]], [[3n8m]], [[3n7y]], [[3n84]], [[3mxc]], [[3mxy]], [[3ov1]], [[3ove]], [[3s8l]], [[3s8n]], [[3s8o]], [[1zfp]] – hGRB2 SH2 domain + phosphor-Tyr peptide<br /> | **[[1tze]], [[1bmb]], [[1bm2]], [[1zfp]], [[1fyr]], [[1jyq]], [[1jyr]], [[2h5k]], [[3c7i]], [[3imd]], [[3imj]], [[3in7]], [[3in8]], [[3kfj]], [[3n8m]], [[3n7y]], [[3n84]], [[3mxc]], [[3mxy]], [[3ov1]], [[3ove]], [[3s8l]], [[3s8n]], [[3s8o]], [[1zfp]] – hGRB2 SH2 domain + phosphor-Tyr peptide<br /> | ||
[[1qg1]] – hGRB2 SH2 domain + phosphor-Tyr peptide - NMR<br /> | **[[1qg1]] – hGRB2 SH2 domain + phosphor-Tyr peptide - NMR<br /> | ||
[[3wa4]] - hGRB2 SH2 domain + CD28 peptide <br /> | **[[3wa4]] - hGRB2 SH2 domain + CD28 peptide <br /> | ||
*GRB4 | |||
[[4e6r]] – hGRB4 C terminal SH3 domain <br /> | **[[4e6r]] – hGRB4 C terminal SH3 domain <br /> | ||
*GRB7 | |||
[[2qms]] – hGRB7 SH2 domain <br /> | **[[2qms]] – hGRB7 SH2 domain <br /> | ||
[[1mw4]], [[2l4k]] – hGRB7 SH2 domain + phosphor-Tyr peptide - NMR<br /> | **[[1mw4]], [[2l4k]] – hGRB7 SH2 domain + phosphor-Tyr peptide - NMR<br /> | ||
[[3pqz]] – hGRB7 SH2 domain + cyclic peptide <br /> | **[[3pqz]] – hGRB7 SH2 domain + cyclic peptide <br /> | ||
[[1wgr]] – hGRB7 RA domain - NMR<br /> | **[[1wgr]] – hGRB7 RA domain - NMR<br /> | ||
*GRB10 | |||
[[1nrv]] – hGRB10 SH2 domain <br /> | **[[1nrv]] – hGRB10 SH2 domain <br /> | ||
[[3m7f]] – hGRB10 SH2 domain + NEDD4 C2 domain<br /> | **[[3m7f]] – hGRB10 SH2 domain + NEDD4 C2 domain<br /> | ||
[[3hk0]] – hGRB10 RA and PH domains <br /> | **[[3hk0]] – hGRB10 RA and PH domains <br /> | ||
*GRB14 | |||
**[[2aug]] – hGRB14 SH2 domain <br /> | |||
**[[2auh]] – hGRB14 BPS domain + insulin receptor kinase domain<br /> | |||
**[[4k81]] – hGRB14 RA and PH domains + GTPase Hras<br /> | |||
}} | |||
[[Category:Topic Page]] | [[Category:Topic Page]] |
Revision as of 14:39, 26 November 2014
<StructureSection load='1tze' size='350' side='right' caption='Structure of human Grb2 SH2 domain (pink) complex with phosphotyrosyl heptapeptide (gold) (PDB entry 1tze)' scene=>
Growth factor receptor-bound proteins (GRB) are adaptor proteins. GRBs contain SH2, Ras-associated (RA) and pleckstrin homology (PH) domains.
- GRB2 links the epidermal growth factor receptor tyrosine kinase to the activation of Ras and its downstream kinases. GRB2 contains an SH2 domain which binds tyrosine phosphorylated sequences and 2 SH3 domains which direct complex formation of proline-rich sequences. GRB2 is involved in signal transduction.
- GRB7 interacts with EGFR and ephrin receptors and plays a role in itegrin signalling pathway.
- GRB10 interacts with insulin receptor and insulin-like growth factor receptors. For additional details on GRB10 see Grb10 SH2 Domain.
3D structures of Grb3D structures of Grb
Updated on 26-November-2014